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Background: There are scant data in the literature regarding the role of robotic liver surgery. The aim of
the present study was to develop techniques for robotic liver tumour resection and to draw a comparison
with laparoscopic resection.
Methods: Over a 1-year period, nine patients underwent robotic resection of peripherally located
malignant lesions measuring <5 cm. These patients were compared prospectively with 23 patients who
underwent laparoscopic resection of similar tumours at the same institution. Statistical analyses were
performed using Student's t-test, c2-test and Kaplan–Meier survival. All data are expressed as mean 
SEM.
Results: The groups were similar with regards to age, gender and tumour type (P = NS). Tumour size was
similar in both groups (robotic -3.2  1.3 cm vs. laparoscopic -2.9  1.3 cm, P = 0.6). Skin-to-skin
operative time was 259 28 min in the robotic vs. 234 17 min in the laparoscopic group (P = 0.4). There
was no difference between the two groups regarding estimated blood loss (EBL) and resection margin
status. Conversion to an open operation was only necessary in one patient in the robotic group.
Complications were observed in one patient in the robotic and four patients in the laparoscopic groups.
The patients were followed up for a mean of 14 months and disease-free survival (DFS) was equivalent
in both groups (P = 0.6).
Conclusion: The results of this initial study suggest that, for selected liver lesions, a robotic approach
provides similar peri-operative outcomes compared with laparoscopic liver resection (LLR).
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Introduction
The advantages of laparoscopic surgery have been shown in mul-
tiple operative procedures1–3 and its safety in resections for malig-
nancy has been demonstrated.4–7 Over the past decade,
laparoscopic liver resection (LLR) has been shown to be feasible8,9
but despite various techniques having been described, there are
still some limitations to obtaining adequate visualization and
meticulous manipulation of the tissues as a result of a two-
dimensional view and awkward laparoscopic instrumentation.
Robotic surgical technology was developed to overcome these
limitations and the aim of the present study was to investigate the
feasibility of robotic liver tumour resection.
Methods
Between October 2008 and September 2009, nine patients under-
went robotic resection of peripherally located lesions measuring
<5 cm in the liver. These patients were compared with 23 patients
who underwent laparoscopic resection of similar tumours at the
same institution. The selection of either approach depended on
the availability of equipment and familiarity of the surgeon with
the robotic procedure. Patients with malignant lesions were
followed-up with quarterly computed tomography (CT) scans of
This paper was presented at the International Hepato-Pancreato-Biliary
Association Meeting, 18–22 April 2010, Buenos Aires, Argentina.
DOI:10.1111/j.1477-2574.2010.00234.x HPB
HPB 2010, 12, 583–586 © 2010 International Hepato-Pancreato-Biliary Association
the chest, abdomen, pelvis and tumour markers. Patient demo-
graphics, tumour type and size, operative time, estimated blood
loss (EBL), resection margin, complications, length of hospital
stay and disease-free survival (DFS) were documented. Data were
collected into an independent review board approved database.
Statistical analyses were performed using Student’s t-test, c2-test
and Kaplan–Meier survival. All data are expressed as mean 
SEM.
Surgical procedure
Our laparoscopic technique has been described previously.6 The
robotic procedures were undertaken with the patient in a supine
position. The port placement is slightly different for this
approach. The procedures were performed using three trocars for
the robotic instruments and a 12-mm trocar for the first assistant
(Fig. 1). The robotic trocars were triangulated based on the loca-
tion of the tumour. The robotic camera port (12 mm) was
inserted about 20 cm away from the tumour, and 10 cm from the
working robotic ports (8 mm). Robotic Maryland forceps were
employed with bipolar energy and Prograsp forceps in each
robotic arm. The robot is brought in from the right or left shoul-
der of the patient, depending on the location of the tumour. The
first assistant port is placed at least 5 cm inferior and lateral to the
nearest robotic port in order to prevent collisions of instruments
(Fig. 2). A precoagulation technique was employed where the
parenchymal transaction line is pre-coagulated either with a
bipolar or unipolar energy source first. Robotic Maryland forceps
are used to mimic the finger fracture of the parenchyma exposing
the vascular and biliary structures, which are divided subsequently
by the first assistant using a combination of Harmonic scalpel,
clips, scissors or stapler under guidance by the surgeon on the
console with the 3-D view allowing delineation of all these struc-
tures (Fig. 3). After resection is finished, the robot is undocked
and the operation is completed laparoscopically by removing the
specimen and obtaining haemostasis. Tissuelink is also used for
haemostasis on the liver bed. A drain is left in place for most
resections.
Results
The groups were similar with regards to age, gender, tumour type
and tumour size (P = NS). Procedure types were similar in both
Figure 1 Operative photo showing the port sites before docking of
the robot
Figure 2 Operative photo showing instrumentation after docking of
the robot
Figure 3 Intra-operative photo showing robotic parenchymal
transection in a patient with a tumour in segment 5
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groups. There was no difference between the two groups with
regards to operative time, EBL and resection margin (Table 1).
Conversion to an open operation was only necessary in one
patient in the robotic group as a result of parenchymal bleeding
after resection and none in the laparoscopic group. Resection
margins were negative for a tumour at the time of resection.
Complications were seen in 11% of the robotic and 17% of the
laparoscopic procedures. These included intra-operative bleeding
requiring conversion to open in the robotic group and two
instances of post-operative clostridium difficile colitis and one of
post-operative ileus in the laparoscopic group.
Patients were followed up for a mean of 14 months and DFS
and overall survival were similar in both groups (Fig. 4). Eight
patients developed tumour recurrence in the liver during
follow-up [2, robotic; 6, laparoscopic (P = 0.9)]. All of these rep-
resented new tumour recurrence except for one local recurrence,
which was in a patient with hepatocellular carcinoma (HCC) in
the robotic group who developed multifocal tumour recurrence 6
months after resection.
Discussion
To our knowledge, this is the largest study to compare robotic liver
resection with the conventional laparoscopic technique. Laparo-
scopic techniques for liver resection are increasing in popularity.
With increasing experience for both benign and malignant liver
lesions LLR has resulted in comparable and, in some aspects,
better outcomes compared with those undergoing open surgery.
Moreover, financial benefits regarding overall costs compared
with open liver resection have also been demonstrated in the
literature.6 Although there are many technical differences in the
laparoscopic approach in the literature, LLR is reported to have
lower morbidity, intra-operative blood loss, blood transfusion
rate, need for post-operative analgesic drugs and shorter hospital
stay compared with open liver resection.6,7,9
Robotic surgery has received increased attention as a result of
advancements in its technology. Although introduced into in the
late 1990s, robotic surgery has not stimulated enthusiasm outside
the specialties of urology, gynaecology and cardiac surgery. Earlier
studies in general surgery have showed longer operative times and
higher costs as major drawbacks of the technology. With the
refinement of the technology, easier set up, better image quality
and smaller robotic systems, there has been a recent interest in
using the robot for general surgical laparoscopic procedures such
Table 1 Comparison of clinical and operative parameters in each group
Robotic Laparoscopic P
Age 66.6  6.4 years 66.7  9.6 years NS
Gender
Women/Men 2/7 11/12 NS
Tumour size 3.2  1.3 cm 2.9  1.3 cm NS
Tumour type
Colorectal metastasis 4 14 NS
Hepatocellular Cancer 3 7
Others 2 2
Surgical procedure
Segmental liver resection 6 12 NS
Left lateral sectionectomy 3 11
Margin 11  8 mm 14  10 mm NS
Operative time 258.5  27.9 mn 233.6  16.4 mn NS
EBL 136  61 cc 155  54 cc NS
EBL, estimated blood loss.
Others include one sarcoma metastasis and one cholangiocellular cancer in the Robotic and one gastrointestinal stromal tumour metastasis and one
carcinoid tumour metastasis in the laparoscopic group.
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Figure 4 Kaplan–Meier disease-free survival (DFS) curves in each
group (P = 0.6). Solid line represents the laparoscopic and broken
line, the robotic group
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as complex hepatopancreatobiliary cases, rectal surgery and
thyroidectomy.10–13
LLR techniques have evolved differently compared with the
open approach. Traditional open resection depends on individual
dissection and ligation/division of vascular and biliary structures;
whereas, laparoscopic resection has relied on staplers and pre-
coagulation instruments, such as monopolar and bipolar radio-
frequency devices. Robotic technology has an opportunity to
mimic open surgery, because of the image quality and dexterity of
the instruments. The robotic camera platform is stable and pro-
vides a realistic 3-D image to the operating surgeon at the console
with excellent visualization of the operative field.14,15 Robotic
instruments provide seven degrees of safe freedom with multi-
articulated hand-like motions and a hand-tremor filtering system
facilitating both gentle and precise dissection within a narrow and
remote field.16 In the present study, we have found the robotic
system satisfactory in identifying and dealing with vascular and
biliary structures distinctly and individually.11 This enables a very
precise dissection and safe parenchymal division.
We have also found the laparoscopic hook TissueLink effective
for haemostasis in our technique. This device involves the use of
RF energy with a saline infusion, which provides an excellent
quality of haemostasis on the liver parenchyma in our experience.
As a result of the additional RF effect, it also has the potential to
contribute to the surgical margin in malignancy cases.
The drawback of the robotic technique is that there is signifi-
cant dependence on the first assistant. The practice of undertaking
the procedure with two staff surgeons has been beneficial as the
possibility of requiring to convert to an open procedure is reduced
by having an experienced first assistant.
However, the lack of access to a 3-D view did result in occa-
sional intra-operative confusion for the first assistant. The detail
to which the surgeon can identify small vascular structures differs
considerably than for the first assistant on the laparoscopic
monitor. Therefore, we believe that there is a need to develop
better quality monitors or 3-D monitors for the first assistant.
The additional cost incurred by the robot is a concern when
justifying its use. Although a case-by-case cost analysis was not
done, the robotic instrumentation in general adds $500 per case to
the laparoscopic equipment cost. The cost of buying the equip-
ment and annual service fees are an additional financial burden of
robotic procedures. These can be reduced with heavy utilization of
the robot by the other surgical specialties at our institution.
In the present study, peri-operative outcomes were similar
between robotic and conventional liver resection groups, with the
robotic procedures taking about 25 min longer. We believe that
this additional time is related to the learning curve of the surgical
team, including unfamiliarity of operating room staff to the new
technology and set-up.
In conclusion, the results of this initial study suggest that, for
selected liver lesions, the robotic approach provides similar
peri-operative outcomes compared with the LLR, but with better
visualization and dexterity. The robotic approach merits further
attention because of its potential to mimic open liver resection.
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